Navigation Links
California Stem Cell and ALS Therapy Development Institute Extend Their Collaboration to Advance Potential Stem Cell Assisted Therapy for ALS
Date:2/2/2010

Collaboration will further evaluate novel stem cell-derived product for the treatment of fatal neurodegenerative disease by regulating genes relevant to disease progression

CAMBRIDGE, Mass. and IRVINE, Calif., Feb. 2 /PRNewswire-USNewswire/ -- California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.  

In this round of experiments, ALS TDI will use a CSC high-purity line of stem cells, called MotorGraft™, to deliver gene expression modifying payloads to specific locations within the central nervous system.  The Institute's "Knowledgesphere", a database of information on gene and protein expression changes related to disease, contains several gene candidates to transfect into stem cells and deliver into the body.  The initial phase of this new collaboration will confirm the expression of these genes in vivo.  Once expression is confirmed, the collaborators will initiate the second phase of this new collaboration, which calls for several full efficacy experiments in order to measure for any potential ameliorating disease.  Members of the CSC science team will travel to ALS TDI to administer the stem cells as part of each experiment.

"As part of our mission, we feel it prudent to work in this arena and will do our part to help advance the understanding of how stem cells could be used to aid in the slowing or stopping of ALS disease progression.  We were encouraged b
'/>"/>

SOURCE ALS Therapy Development Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Novocell Receives a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes
2. Southern California Venture Network Announces Recipients of the 2009 Orange County Emerging Growth Awards
3. Southern California Venture Network to Recognize Local Companies At 2009 Emerging Growth Awards
4. California Life Science, Business, and Economic Development Experts Discuss Californias Bioscience Future
5. California Bioscience Business Roundtable Aug. 26th
6. Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009
7. Genoptix Announces Participation at the 2009 Southern California Investor Conference
8. ClinfoSource and California State University, East Bay Jointly Launch On-Line Certificate Program in Clinical Research
9. UCLA welcomes startup to new incubator space at California NanoSystems Institute
10. GreenHouse Energy, Governor Schwarzenegger Join in Driving the Future of Fueling in California
11. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Oven Industries Inc. announces a new ... 5R6-900 benchtop controller has many outstanding user-friendly benefits. Contained ... into the wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... can also be used universally, which allows the user ...
(Date:5/20/2013)... 2013  Dr. Gerald Zon , ... recently launched a new blog in conjunction with TriLink ... ), focuses on what,s trending in the field of ... leaders, discussions of research presented at conferences and meetings, ... Dr. Zon (PhD Princeton University 1971) developed automated synthesis ...
(Date:5/20/2013)... , May 20, 2013 Cempra, Inc. ... developing differentiated antibiotics to meet critical medical needs ... that it presented data at the American Thoracic ... Philadelphia demonstrating the antibacterial and enhanced ... prior Phase 2 clinical trial in outpatients with ...
(Date:5/20/2013)... May 20, 2013 Researchers from the ... connection between lower back pain, and the acne causing P.acnes ... the system the bacteria seek out oxygen deprived location to ... the spinal column, P.acnes has the ability to live in ... Fernando Perez, a spokesman for “ The best acne treatment ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Executive Officer of BioMarin, will host a ... 28, at 5:00 p.m. ET to discuss ... Dial-in Number:  888.396.2386International Dial-in Number:  617.847.8712Participant Code: ...
... 28, 2011 The Japanese nuclear crisis has caused ... shortages not only in Japan, but as far away ... potassium iodide does not provide generalized radiation protection because ... being bombarded with orders as the radiation hysteria mounts. ...
... CAMBRIDGE, Mass. -- In recent years, many airplane manufacturers ... which consist of high-strength fibers, such as carbon or ... materials are stronger and more lightweight than aluminum, but ... because their surfaces usually don,t reveal underlying problems. ...
Cached Biology Technology:BioMarin to Host First Quarter 2011 Financial Results Conference Call and Webcast on Thursday, April 28 at 5:00 p.m. ET 2Shortages of Potassium Iodide as Radiation Panic Drives Demand 2MIT engineers devise new way to inspect materials used in airplanes 2
(Date:5/19/2013)... Davis have engineered a strain of photosynthetic cyanobacteria to ... their findings today at the 113th General Meeting of ... we used synthetic biology approaches to probe and rewire ... for growth) cyanobacterial metabolism for the ability to grow ... on the study. He is part of Shota ...
(Date:5/18/2013)... 2013) Research presented at Digestive Disease Week ... through diet and lifestyle. , Individuals suffering ... muscle strength, fatigue and poor quality of life. ... in remission. A randomized, double blind, placebo-controlled study ... supplementation corresponded to significant relief of these symptoms. ...
(Date:5/17/2013)... By day, insects provide the white noise of the South, ... typical year, the Southern air hangs heavy from the humidity ... to more than 140 species of frogs, toads and salamanders, ... If the ponds and swamps are the auditorium for their ... Research and Monitoring Initiative, or ARMI, have front-row seats. ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... July 28, 2011 A paper published today in ... novel, proprietary monoclonal antibody (FI6) discovered in a collaboration ... Biomedicine ("IRB") and the UK Medical Research Council (MRC). ... 16 hemagglutinin subtypes of influenza A and represents an ...
... Escape responses are some of the most studied ... brain processes sensory information. The ability to evade predators ... selection. Animals explore their environment to find food, find ... escape responses to avoid predators, thereby increasing their chances ...
... approach which focuses on understanding the complex relationships ... of an aggressive form of breast cancer, researchers for ... in the blood that change in abundance long before ... Christopher Kemp, Ph.D., and Samir Hanash, M.D., Ph.D., members ...
Cached Biology News:Humabs discovers the first antibody to neutralize both group 1 and group 2 influenza A viruses 2Elusive prey 2Using a 'systems biology' approach to look under the hood of an aggressive form of breast cancer 2
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215...
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454...
Glutathione Agarose Beads 10 ml...
...
Biology Products: